EverSource Wealth Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

EverSource Wealth Advisors’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-267	Closed	-$1.08K	–	3025
2023 Q4	$1.08K	Buy	+267	New	+$815	﹤0.01%	2380

EverSource Wealth Advisors's THRX Position: Q1 2024 in Review

EverSource Wealth Advisors sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 267 shares — an estimated $1.08K sold.

EverSource Wealth Advisors first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $1.08K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

EverSource Wealth Advisors reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
EverSource Wealth Advisors sold 267 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $1.08K.
EverSource Wealth Advisors first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
EverSource Wealth Advisors's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $1.08K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on EverSource Wealth Advisors's 13F filing for Q1 2024, filed 13 May 2024.